您的位置: 首页 > 农业专利 > 详情页

Ocular Neostigmine Drops for Diagnosing Myasthenia Gravis
专利权人:
Mustafa A.M. Salih
发明人:
Mustafa A.M. Salih,Mohamed A.M. Salih,Ali A. Mustafa,Thomas M. Bosley
申请号:
US13892624
公开号:
US20140335021A1
申请日:
2013.05.13
申请国别(地区):
US
年份:
2014
代理人:
摘要:
Disclosed is a method for aiding in the diagnosis of myasthenia gravis. Neostigmine, for example one drop of standard intravenous neostigmine solution (2.5 mg/ml) is instilled into each symptomatic or ptotic eye of patients with suspected or probable myasthenia gravis. The patient is later evaluated for possible changes in ptosis. An observable increase of the palpebral fissure height of at least 2 mm, e.g., after 30-60 minutes after neostigmine instillation is considered to be diagnostic.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充